NCT02356016

Brief Summary

The aim of the study is to determine the effect of whole body electromyostimulation (WB-EMS) and/or nutritional on body composition and functional tasks in elderly females with sarcopenic obesity. Seventy-five, non-sportive, independently living women 70 years and older with Sarcopenic Obesity were randomly assigned to either a WB-EMS group ( n=25), a WB-EMS/nutritional supplements (n=25) or a semi-active control group (an=25). The WB-EMS protocol applied one session of 18 min/week of WB-EMS (bipolar, 85 Hz). Nutritional strategy based on a high protein supplement.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

January 21, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 5, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

May 23, 2016

Status Verified

May 1, 2016

Enrollment Period

2.8 years

First QC Date

January 21, 2015

Last Update Submit

May 20, 2016

Conditions

Keywords

Sarcopenic Obesitycommunity dwelling elderly womenelectromyostimulationexercisedietary supplements

Outcome Measures

Primary Outcomes (3)

  • Appendicular skeletal muscle mass

    changes of appendicular skeletal muscle mass from baseline to 6 month follow-up

    baseline - 6 months follow-up

  • Muscle density of the medial thigh

    changes of muscle density (thigh) from baseline to 6 month follow-up

    baseline - 6 months follow-up

  • Intramuscular fat content

    changes of Intramuscular fat content (thigh) from baseline to 6 month follow-up

    baseline - 6 months follow-up

Secondary Outcomes (5)

  • Muscle cross sectional area (CSA)

    baseline - 6 months follow-up

  • Isokinetic leg strength

    baseline - 6 months follow-up

  • Short Physical Performance Battery (SPPB)

    baseline - 6 months follow-up

  • Hand grip of the dominant hand

    baseline - 6 months follow-up

  • muscular power of the legs

    baseline - 6 months follow-up

Other Outcomes (3)

  • Balance according to SPPB

    baseline - 6 months follow-up

  • Quality of life

    baseline - 6 months follow-up

  • Trial Making Tests A and B

    baseline - 6 months follow-up

Study Arms (3)

Whole body Electromyostimulation (WB-EMS)

ACTIVE COMPARATOR

18 min of WB-EMS/week (one session/week)

Behavioral: WB-EMS Intervention

WB-EMS and Nutritional Supplements

ACTIVE COMPARATOR

18 min of WB-EMS/week (one session/week) and supplements with high protein (Leucin) contents

Behavioral: WB-EMS-Intervention and dietary supplementation

Control

SHAM COMPARATOR

Monthly dietary counseling for 6 months

Other: control (dietary counseling)

Interventions

Supervised WB-EMS Intervention 18 min/session (one session/week) and monthly dietary counseling for 6 months

Whole body Electromyostimulation (WB-EMS)

Supervised WB-EMS Intervention and dietary supplementation and monthly dietary counseling for 6 months

WB-EMS and Nutritional Supplements

Monthly dietary counseling only

Control

Eligibility Criteria

Age70 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • community dwelling
  • Sarcopenic Obesity

You may not qualify if:

  • exercising more than 60 min/week
  • more than 4 weeks absent during the interventional period,
  • injuries (i.e. hip TotalEndoProsthesis (TEP), abdomen/groin hernia) or diseases (i.e. epilepsy, cardiac arrhythmia) that prevent WB-EMS intervention
  • medication and/or diseases affecting our primary endpoints.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Kemmler W, Bebenek M, Engelke K, von Stengel S. Impact of whole-body electromyostimulation on body composition in elderly women at risk for sarcopenia: the Training and ElectroStimulation Trial (TEST-III). Age (Dordr). 2014 Feb;36(1):395-406. doi: 10.1007/s11357-013-9575-2. Epub 2013 Aug 16.

    PMID: 23949160BACKGROUND
  • Kemmler W, von Stengel S. Whole-body electromyostimulation as a means to impact muscle mass and abdominal body fat in lean, sedentary, older female adults: subanalysis of the TEST-III trial. Clin Interv Aging. 2013;8:1353-64. doi: 10.2147/CIA.S52337. Epub 2013 Oct 7.

    PMID: 24130433BACKGROUND
  • Kemmler W, Teschler M, Weissenfels A, Bebenek M, von Stengel S, Kohl M, Freiberger E, Goisser S, Jakob F, Sieber C, Engelke K. Whole-body electromyostimulation to fight sarcopenic obesity in community-dwelling older women at risk. Resultsof the randomized controlled FORMOsA-sarcopenic obesity study. Osteoporos Int. 2016 Nov;27(11):3261-3270. doi: 10.1007/s00198-016-3662-z. Epub 2016 Jun 12.

MeSH Terms

Conditions

Motor Activity

Interventions

Dietary SupplementsNutrition Assessment

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Cornel Sieber, MD

    Institute of Biomedicine of Age, University of Erlangen-Nuremberg

    STUDY CHAIR
  • Cornelius Bollheimer, MD

    Institute of Biomedicine of Age, University of Erlangen-Nuremberg

    STUDY CHAIR
  • Klaus Engelke, PhD

    Institute of Medical Physics, University of Erlangen-Nuremberg

    STUDY DIRECTOR
  • Wolfgang Kemmler, PHD

    Institute of Medical Physics, University of Erlangen-Nuremberg

    PRINCIPAL INVESTIGATOR
  • Ellen Freiberger, PhD

    Institute of Biomedicine of Age, University of Erlangen-Nuremberg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2015

First Posted

February 5, 2015

Study Start

August 1, 2013

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

May 23, 2016

Record last verified: 2016-05